[
{
"old_id":"1",
"old_nametree":"Summary cards",
"old_numtree":"8.0.0.0",
"old_htmlpage":"null",
"new_id":"91",
"new_nametree":"Summary cards",
"new_numtree":"1.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"2",
"old_nametree":"Myocardial dysfunction and heart failure",
"old_numtree":"1.1.0.0",
"old_htmlpage":"ENAS5193_2017063092",
"new_id":"92",
"new_nametree":"Myocardial dysfunction and heart failure",
"new_numtree":"1.1.0.0",
"new_htmlpage":"ENAS5193_2017063092"
},
{
"old_id":"3",
"old_nametree":"Baseline risk factors for cardiotoxicity",
"old_numtree":"1.2.0.0",
"old_htmlpage":"ENAS5193_2017063093",
"new_id":"93",
"new_nametree":"Baseline risk factors for cardiotoxicity",
"new_numtree":"1.2.0.0",
"new_htmlpage":"ENAS5193_2017063093"
},
{
"old_id":"4",
"old_nametree":"Key points",
"old_numtree":"1.3.0.0",
"old_htmlpage":"ENAS5193_2017063094",
"new_id":"94",
"new_nametree":"Key points",
"new_numtree":"1.3.0.0",
"new_htmlpage":"ENAS5193_2017063094"
},
{
"old_id":"5",
"old_nametree":"Coronary artery disease",
"old_numtree":"1.4.0.0",
"old_htmlpage":"ENAS5193_2017063095",
"new_id":"95",
"new_nametree":"Coronary artery disease",
"new_numtree":"1.4.0.0",
"new_htmlpage":"ENAS5193_2017063095"
},
{
"old_id":"6",
"old_nametree":"Arrhythmias",
"old_numtree":"1.5.0.0",
"old_htmlpage":"ENAS5193_2017063096",
"new_id":"96",
"new_nametree":"Arrhythmias",
"new_numtree":"1.5.0.0",
"new_htmlpage":"ENAS5193_2017063096"
},
{
"old_id":"7",
"old_nametree":"QT prolongation",
"old_numtree":"1.6.0.0",
"old_htmlpage":"ENAS5193_2017063097",
"new_id":"97",
"new_nametree":"QT prolongation",
"new_numtree":"1.6.0.0",
"new_htmlpage":"ENAS5193_2017063097"
},
{
"old_id":"8",
"old_nametree":"Atrial fibrillation",
"old_numtree":"1.7.0.0",
"old_htmlpage":"ENAS5193_2017063098",
"new_id":"98",
"new_nametree":"Atrial fibrillation",
"new_numtree":"1.7.0.0",
"new_htmlpage":"ENAS5193_2017063098"
},
{
"old_id":"9",
"old_nametree":"Thromboembolic disease",
"old_numtree":"1.8.0.0",
"old_htmlpage":"ENAS5193_2017063099",
"new_id":"99",
"new_nametree":"Thromboembolic disease",
"new_numtree":"1.8.0.0",
"new_htmlpage":"ENAS5193_2017063099"
},
{
"old_id":"10",
"old_nametree":"Prevention of cardiotoxicity",
"old_numtree":"1.9.0.0",
"old_htmlpage":"ENAS5193_20170630100",
"new_id":"100",
"new_nametree":"Prevention of cardiotoxicity",
"new_numtree":"1.9.0.0",
"new_htmlpage":"ENAS5193_20170630100"
},
{
"old_id":"11",
"old_nametree":"Authors and legal information",
"old_numtree":"1.0.0.0",
"old_htmlpage":"ENAS5193_1.0.0.0",
"new_id":"1",
"new_nametree":"Authors and legal information",
"new_numtree":"2.0.0.0",
"new_htmlpage":"ENAS5193_1.0.0.0"
},
{
"old_id":"12",
"old_nametree":"Introduction",
"old_numtree":"2.0.0.0",
"old_htmlpage":"ENAS5193_2.0.0.0",
"new_id":"2",
"new_nametree":"Introduction",
"new_numtree":"3.0.0.0",
"new_htmlpage":"ENAS5193_2.0.0.0"
},
{
"old_id":"13",
"old_nametree":"CV complications: pathophysio. & mgmt.",
"old_numtree":"3.0.0.0",
"old_htmlpage":"null",
"new_id":"3",
"new_nametree":"CV complications: pathophysio. & mgmt.",
"new_numtree":"4.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"14",
"old_nametree":"Myocardial dysfunction and heart failure",
"old_numtree":"3.1.0.0",
"old_htmlpage":"null",
"new_id":"4",
"new_nametree":"Myocardial dysfunction and heart failure",
"new_numtree":"4.1.0.0",
"new_htmlpage":"null"
},
{
"old_id":"15",
"old_nametree":"Pathophysiology and clinical presentation",
"old_numtree":"3.1.1.0",
"old_htmlpage":"null",
"new_id":"5",
"new_nametree":"Pathophysiology and clinical presentation",
"new_numtree":"4.1.1.0",
"new_htmlpage":"null"
},
{
"old_id":"16",
"old_nametree":"Overview",
"old_numtree":"3.1.1.1",
"old_htmlpage":"ENAS5193_3.1.1.1",
"new_id":"6",
"new_nametree":"Overview",
"new_numtree":"4.1.1.1",
"new_htmlpage":"ENAS5193_3.1.1.1"
},
{
"old_id":"17",
"old_nametree":"Anthracyclines",
"old_numtree":"3.1.1.2",
"old_htmlpage":"ENAS5193_3.1.1.2",
"new_id":"7",
"new_nametree":"Anthracyclines",
"new_numtree":"4.1.1.2",
"new_htmlpage":"ENAS5193_3.1.1.2"
},
{
"old_id":"18",
"old_nametree":"Other conventional chemotherapies",
"old_numtree":"3.1.1.3",
"old_htmlpage":"ENAS5193_3.1.1.3",
"new_id":"8",
"new_nametree":"Other conventional chemotherapies",
"new_numtree":"4.1.1.3",
"new_htmlpage":"ENAS5193_3.1.1.3"
},
{
"old_id":"19",
"old_nametree":"Immunotherapies and targeted therapies",
"old_numtree":"3.1.1.4",
"old_htmlpage":"ENAS5193_3.1.1.4",
"new_id":"9",
"new_nametree":"Immunotherapies and targeted therapies",
"new_numtree":"4.1.1.4",
"new_htmlpage":"ENAS5193_3.1.1.4"
},
{
"old_id":"20",
"old_nametree":"VEGF pathway inhibition",
"old_numtree":"3.1.1.5",
"old_htmlpage":"ENAS5193_3.1.1.5",
"new_id":"10",
"new_nametree":"VEGF pathway inhibition",
"new_numtree":"4.1.1.5",
"new_htmlpage":"ENAS5193_3.1.1.5"
},
{
"old_id":"21",
"old_nametree":"Inhibition of BCR-ABL kinase",
"old_numtree":"3.1.1.6",
"old_htmlpage":"ENAS5193_3.1.1.6",
"new_id":"11",
"new_nametree":"Inhibition of BCR-ABL kinase",
"new_numtree":"4.1.1.6",
"new_htmlpage":"ENAS5193_3.1.1.6"
},
{
"old_id":"22",
"old_nametree":"Proteasome inhibitors",
"old_numtree":"3.1.1.7",
"old_htmlpage":"ENAS5193_3.1.1.7",
"new_id":"12",
"new_nametree":"Proteasome inhibitors",
"new_numtree":"4.1.1.7",
"new_htmlpage":"ENAS5193_3.1.1.7"
},
{
"old_id":"23",
"old_nametree":"Radiotherapy",
"old_numtree":"3.1.1.8",
"old_htmlpage":"ENAS5193_3.1.1.8",
"new_id":"13",
"new_nametree":"Radiotherapy",
"new_numtree":"4.1.1.8",
"new_htmlpage":"ENAS5193_3.1.1.8"
},
{
"old_id":"24",
"old_nametree":"Diagnostic & therapeutic mgmt.",
"old_numtree":"3.1.2.0",
"old_htmlpage":"null",
"new_id":"14",
"new_nametree":"Diagnostic & therapeutic mgmt.",
"new_numtree":"4.1.2.0",
"new_htmlpage":"null"
},
{
"old_id":"25",
"old_nametree":"Screening, risk strat., & early detect. strategies",
"old_numtree":"3.1.2.1",
"old_htmlpage":"ENAS5193_3.1.2.1",
"new_id":"15",
"new_nametree":"Screening, risk strat., & early detect. strategies",
"new_numtree":"4.1.2.1",
"new_htmlpage":"ENAS5193_3.1.2.1"
},
{
"old_id":"26",
"old_nametree":"CV mgmt. w/ anthracyclines",
"old_numtree":"3.1.2.2",
"old_htmlpage":"ENAS5193_3.1.2.2",
"new_id":"16",
"new_nametree":"CV mgmt. w/ anthracyclines",
"new_numtree":"4.1.2.2",
"new_htmlpage":"ENAS5193_3.1.2.2"
},
{
"old_id":"27",
"old_nametree":"CV mgmt. w/ anti-HER2",
"old_numtree":"3.1.2.3",
"old_htmlpage":"ENAS5193_3.1.2.3",
"new_id":"17",
"new_nametree":"CV mgmt. w/ anti-HER2",
"new_numtree":"4.1.2.3",
"new_htmlpage":"ENAS5193_3.1.2.3"
},
{
"old_id":"28",
"old_nametree":"CV mgmt. w/ VEGF inhibitors",
"old_numtree":"3.1.2.4",
"old_htmlpage":"ENAS5193_3.1.2.4",
"new_id":"18",
"new_nametree":"CV mgmt. w/ VEGF inhibitors",
"new_numtree":"4.1.2.4",
"new_htmlpage":"ENAS5193_3.1.2.4"
},
{
"old_id":"29",
"old_nametree":"Screening and early detection strategies",
"old_numtree":"3.1.2.5",
"old_htmlpage":"ENAS5193_3.1.2.5",
"new_id":"19",
"new_nametree":"Screening and early detection strategies",
"new_numtree":"4.1.2.5",
"new_htmlpage":"ENAS5193_3.1.2.5"
},
{
"old_id":"30",
"old_nametree":"Diag. tools to detect myocardial toxicity",
"old_numtree":"3.1.2.6",
"old_htmlpage":"ENAS5193_3.1.2.6",
"new_id":"20",
"new_nametree":"Diag. tools to detect myocardial toxicity",
"new_numtree":"4.1.2.6",
"new_htmlpage":"ENAS5193_3.1.2.6"
},
{
"old_id":"31",
"old_nametree":"Key points",
"old_numtree":"3.1.3.0",
"old_htmlpage":"ENAS5193_3.1.3.0",
"new_id":"21",
"new_nametree":"Key points",
"new_numtree":"4.1.3.0",
"new_htmlpage":"ENAS5193_3.1.3.0"
},
{
"old_id":"32",
"old_nametree":"Coronary artery disease",
"old_numtree":"3.2.0.0",
"old_htmlpage":"null",
"new_id":"22",
"new_nametree":"Coronary artery disease",
"new_numtree":"4.2.0.0",
"new_htmlpage":"null"
},
{
"old_id":"33",
"old_nametree":"Pathophysiology and clinical presentation",
"old_numtree":"3.2.1.0",
"old_htmlpage":"null",
"new_id":"23",
"new_nametree":"Pathophysiology and clinical presentation",
"new_numtree":"4.2.1.0",
"new_htmlpage":"null"
},
{
"old_id":"34",
"old_nametree":"Overview",
"old_numtree":"3.2.1.1",
"old_htmlpage":"ENAS5193_3.2.1.1",
"new_id":"24",
"new_nametree":"Overview",
"new_numtree":"4.2.1.1",
"new_htmlpage":"ENAS5193_3.2.1.1"
},
{
"old_id":"35",
"old_nametree":"Fluoropyrimidines",
"old_numtree":"3.2.1.2",
"old_htmlpage":"ENAS5193_3.2.1.2",
"new_id":"25",
"new_nametree":"Fluoropyrimidines",
"new_numtree":"4.2.1.2",
"new_htmlpage":"ENAS5193_3.2.1.2"
},
{
"old_id":"36",
"old_nametree":"Radiotherapy",
"old_numtree":"3.2.1.3",
"old_htmlpage":"ENAS5193_3.2.1.3",
"new_id":"26",
"new_nametree":"Radiotherapy",
"new_numtree":"4.2.1.3",
"new_htmlpage":"ENAS5193_3.2.1.3"
},
{
"old_id":"37",
"old_nametree":"Diagnostic & therapeutic mgmt.",
"old_numtree":"3.2.2.0",
"old_htmlpage":"ENAS5193_3.2.2.0",
"new_id":"27",
"new_nametree":"Diagnostic & therapeutic mgmt.",
"new_numtree":"4.2.2.0",
"new_htmlpage":"ENAS5193_3.2.2.0"
},
{
"old_id":"38",
"old_nametree":"Key points",
"old_numtree":"3.2.3.0",
"old_htmlpage":"ENAS5193_3.2.3.0",
"new_id":"28",
"new_nametree":"Key points",
"new_numtree":"4.2.3.0",
"new_htmlpage":"ENAS5193_3.2.3.0"
},
{
"old_id":"39",
"old_nametree":"Valvular disease",
"old_numtree":"3.3.0.0",
"old_htmlpage":"null",
"new_id":"29",
"new_nametree":"Valvular disease",
"new_numtree":"4.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"40",
"old_nametree":"Pathophysiology and clinical presentation",
"old_numtree":"3.3.1.0",
"old_htmlpage":"ENAS5193_3.3.1.0",
"new_id":"30",
"new_nametree":"Pathophysiology and clinical presentation",
"new_numtree":"4.3.1.0",
"new_htmlpage":"ENAS5193_3.3.1.0"
},
{
"old_id":"41",
"old_nametree":"Diagnostic & therapeutic mgmt.",
"old_numtree":"3.3.2.0",
"old_htmlpage":"ENAS5193_3.3.2.0",
"new_id":"31",
"new_nametree":"Diagnostic & therapeutic mgmt.",
"new_numtree":"4.3.2.0",
"new_htmlpage":"ENAS5193_3.3.2.0"
},
{
"old_id":"42",
"old_nametree":"Arrhythmias",
"old_numtree":"3.4.0.0",
"old_htmlpage":"null",
"new_id":"32",
"new_nametree":"Arrhythmias",
"new_numtree":"4.4.0.0",
"new_htmlpage":"null"
},
{
"old_id":"43",
"old_nametree":"Pathophysiology and clinical presentation",
"old_numtree":"3.4.1.0",
"old_htmlpage":"null",
"new_id":"33",
"new_nametree":"Pathophysiology and clinical presentation",
"new_numtree":"4.4.1.0",
"new_htmlpage":"null"
},
{
"old_id":"44",
"old_nametree":"Overview",
"old_numtree":"3.4.1.1",
"old_htmlpage":"ENAS5193_3.4.1.1",
"new_id":"34",
"new_nametree":"Overview",
"new_numtree":"4.4.1.1",
"new_htmlpage":"ENAS5193_3.4.1.1"
},
{
"old_id":"45",
"old_nametree":"QT prolongation",
"old_numtree":"3.4.1.2",
"old_htmlpage":"ENAS5193_3.4.1.2",
"new_id":"35",
"new_nametree":"QT prolongation",
"new_numtree":"4.4.1.2",
"new_htmlpage":"ENAS5193_3.4.1.2"
},
{
"old_id":"46",
"old_nametree":"Supraventricular arrhythmia",
"old_numtree":"3.4.1.3",
"old_htmlpage":"ENAS5193_3.4.1.3",
"new_id":"36",
"new_nametree":"Supraventricular arrhythmia",
"new_numtree":"4.4.1.3",
"new_htmlpage":"ENAS5193_3.4.1.3"
},
{
"old_id":"47",
"old_nametree":"Ventricular arrhythmias",
"old_numtree":"3.4.1.4",
"old_htmlpage":"ENAS5193_3.4.1.4",
"new_id":"37",
"new_nametree":"Ventricular arrhythmias",
"new_numtree":"4.4.1.4",
"new_htmlpage":"ENAS5193_3.4.1.4"
},
{
"old_id":"48",
"old_nametree":"Sinus node dysfunction and conduction defects",
"old_numtree":"3.4.1.5",
"old_htmlpage":"ENAS5193_3.4.1.5",
"new_id":"38",
"new_nametree":"Sinus node dysfunction and conduction defects",
"new_numtree":"4.4.1.5",
"new_htmlpage":"ENAS5193_3.4.1.5"
},
{
"old_id":"49",
"old_nametree":"Diagnostic & therapeutic mgmt.",
"old_numtree":"3.4.2.0",
"old_htmlpage":"null",
"new_id":"39",
"new_nametree":"Diagnostic & therapeutic mgmt.",
"new_numtree":"4.4.2.0",
"new_htmlpage":"null"
},
{
"old_id":"50",
"old_nametree":"QT interval & risk fact. for QT prolongation",
"old_numtree":"3.4.2.1",
"old_htmlpage":"ENAS5193_3.4.2.1",
"new_id":"40",
"new_nametree":"QT interval & risk fact. for QT prolongation",
"new_numtree":"4.4.2.1",
"new_htmlpage":"ENAS5193_3.4.2.1"
},
{
"old_id":"51",
"old_nametree":"Atrial fibrillation and atrial flutter",
"old_numtree":"3.4.2.2",
"old_htmlpage":"ENAS5193_3.4.2.2",
"new_id":"41",
"new_nametree":"Atrial fibrillation and atrial flutter",
"new_numtree":"4.4.2.2",
"new_htmlpage":"ENAS5193_3.4.2.2"
},
{
"old_id":"52",
"old_nametree":"Bradycardia or atrioventricular block",
"old_numtree":"3.4.2.3",
"old_htmlpage":"ENAS5193_3.4.2.3",
"new_id":"42",
"new_nametree":"Bradycardia or atrioventricular block",
"new_numtree":"4.4.2.3",
"new_htmlpage":"ENAS5193_3.4.2.3"
},
{
"old_id":"53",
"old_nametree":"Arterial hypertension",
"old_numtree":"3.5.0.0",
"old_htmlpage":"null",
"new_id":"43",
"new_nametree":"Arterial hypertension",
"new_numtree":"4.5.0.0",
"new_htmlpage":"null"
},
{
"old_id":"54",
"old_nametree":"Pathophysiology and clinical presentation",
"old_numtree":"3.5.1.0",
"old_htmlpage":"ENAS5193_3.5.1.0",
"new_id":"44",
"new_nametree":"Pathophysiology and clinical presentation",
"new_numtree":"4.5.1.0",
"new_htmlpage":"ENAS5193_3.5.1.0"
},
{
"old_id":"55",
"old_nametree":"Diagnostic & therapeutic mgmt.",
"old_numtree":"3.5.2.0",
"old_htmlpage":"ENAS5193_3.5.2.0",
"new_id":"45",
"new_nametree":"Diagnostic & therapeutic mgmt.",
"new_numtree":"4.5.2.0",
"new_htmlpage":"ENAS5193_3.5.2.0"
},
{
"old_id":"56",
"old_nametree":"Key points",
"old_numtree":"3.5.3.0",
"old_htmlpage":"ENAS5193_3.5.3.0",
"new_id":"46",
"new_nametree":"Key points",
"new_numtree":"4.5.3.0",
"new_htmlpage":"ENAS5193_3.5.3.0"
},
{
"old_id":"57",
"old_nametree":"Thromboembolic disease",
"old_numtree":"3.6.0.0",
"old_htmlpage":"null",
"new_id":"47",
"new_nametree":"Thromboembolic disease",
"new_numtree":"4.6.0.0",
"new_htmlpage":"null"
},
{
"old_id":"58",
"old_nametree":"Pathophysiology and clinical presentation",
"old_numtree":"3.6.1.0",
"old_htmlpage":"null",
"new_id":"48",
"new_nametree":"Pathophysiology and clinical presentation",
"new_numtree":"4.6.1.0",
"new_htmlpage":"null"
},
{
"old_id":"59",
"old_nametree":"Overview",
"old_numtree":"3.6.1.1",
"old_htmlpage":"ENAS5193_3.6.1.1",
"new_id":"49",
"new_nametree":"Overview",
"new_numtree":"4.6.1.1",
"new_htmlpage":"ENAS5193_3.6.1.1"
},
{
"old_id":"60",
"old_nametree":"Arterial thrombosis",
"old_numtree":"3.6.1.2",
"old_htmlpage":"ENAS5193_3.6.1.2",
"new_id":"50",
"new_nametree":"Arterial thrombosis",
"new_numtree":"4.6.1.2",
"new_htmlpage":"ENAS5193_3.6.1.2"
},
{
"old_id":"61",
"old_nametree":"Venous thrombosis",
"old_numtree":"3.6.1.3",
"old_htmlpage":"ENAS5193_3.6.1.3",
"new_id":"51",
"new_nametree":"Venous thrombosis",
"new_numtree":"4.6.1.3",
"new_htmlpage":"ENAS5193_3.6.1.3"
},
{
"old_id":"62",
"old_nametree":"Diagnostic & therapeutic mgmt.",
"old_numtree":"3.6.2.0",
"old_htmlpage":"ENAS5193_3.6.2.0",
"new_id":"52",
"new_nametree":"Diagnostic & therapeutic mgmt.",
"new_numtree":"4.6.2.0",
"new_htmlpage":"ENAS5193_3.6.2.0"
},
{
"old_id":"63",
"old_nametree":"Peripheral vascular disease and stroke",
"old_numtree":"3.7.0.0",
"old_htmlpage":"null",
"new_id":"53",
"new_nametree":"Peripheral vascular disease and stroke",
"new_numtree":"4.7.0.0",
"new_htmlpage":"null"
},
{
"old_id":"64",
"old_nametree":"Pathophysiology and clinical presentation",
"old_numtree":"3.7.1.0",
"old_htmlpage":"null",
"new_id":"54",
"new_nametree":"Pathophysiology and clinical presentation",
"new_numtree":"4.7.1.0",
"new_htmlpage":"null"
},
{
"old_id":"65",
"old_nametree":"Peripheral artery disease",
"old_numtree":"3.7.1.1",
"old_htmlpage":"ENAS5193_3.7.1.1",
"new_id":"55",
"new_nametree":"Peripheral artery disease",
"new_numtree":"4.7.1.1",
"new_htmlpage":"ENAS5193_3.7.1.1"
},
{
"old_id":"66",
"old_nametree":"Stroke",
"old_numtree":"3.7.1.2",
"old_htmlpage":"ENAS5193_3.7.1.2",
"new_id":"56",
"new_nametree":"Stroke",
"new_numtree":"4.7.1.2",
"new_htmlpage":"ENAS5193_3.7.1.2"
},
{
"old_id":"67",
"old_nametree":"Diagnostic & therapeutic mgmt.",
"old_numtree":"3.7.2.0",
"old_htmlpage":"ENAS5193_3.7.2.0",
"new_id":"57",
"new_nametree":"Diagnostic & therapeutic mgmt.",
"new_numtree":"4.7.2.0",
"new_htmlpage":"ENAS5193_3.7.2.0"
},
{
"old_id":"68",
"old_nametree":"Pulmonary hypertension",
"old_numtree":"3.8.0.0",
"old_htmlpage":"null",
"new_id":"58",
"new_nametree":"Pulmonary hypertension",
"new_numtree":"4.8.0.0",
"new_htmlpage":"null"
},
{
"old_id":"69",
"old_nametree":"Pathophysiology and clinical presentation",
"old_numtree":"3.8.1.0",
"old_htmlpage":"ENAS5193_3.8.1.0",
"new_id":"59",
"new_nametree":"Pathophysiology and clinical presentation",
"new_numtree":"4.8.1.0",
"new_htmlpage":"ENAS5193_3.8.1.0"
},
{
"old_id":"70",
"old_nametree":"Diagnostic & therapeutic mgmt.",
"old_numtree":"3.8.2.0",
"old_htmlpage":"ENAS5193_3.8.2.0",
"new_id":"60",
"new_nametree":"Diagnostic & therapeutic mgmt.",
"new_numtree":"4.8.2.0",
"new_htmlpage":"ENAS5193_3.8.2.0"
},
{
"old_id":"71",
"old_nametree":"Other CV complications",
"old_numtree":"3.9.0.0",
"old_htmlpage":"null",
"new_id":"61",
"new_nametree":"Other CV complications",
"new_numtree":"4.9.0.0",
"new_htmlpage":"null"
},
{
"old_id":"72",
"old_nametree":"Pericardial disease",
"old_numtree":"3.9.1.0",
"old_htmlpage":"ENAS5193_3.9.1.0",
"new_id":"62",
"new_nametree":"Pericardial disease",
"new_numtree":"4.9.1.0",
"new_htmlpage":"ENAS5193_3.9.1.0"
},
{
"old_id":"73",
"old_nametree":"Pleural effusion",
"old_numtree":"3.9.2.0",
"old_htmlpage":"ENAS5193_3.9.2.0",
"new_id":"63",
"new_nametree":"Pleural effusion",
"new_numtree":"4.9.2.0",
"new_htmlpage":"ENAS5193_3.9.2.0"
},
{
"old_id":"74",
"old_nametree":"Autonomic dysfunction",
"old_numtree":"3.9.3.0",
"old_htmlpage":"ENAS5193_3.9.3.0",
"new_id":"64",
"new_nametree":"Autonomic dysfunction",
"new_numtree":"4.9.3.0",
"new_htmlpage":"ENAS5193_3.9.3.0"
},
{
"old_id":"75",
"old_nametree":"CV complications in special populations",
"old_numtree":"3.10.0.0",
"old_htmlpage":"null",
"new_id":"65",
"new_nametree":"CV complications in special populations",
"new_numtree":"4.10.0.0",
"new_htmlpage":"null"
},
{
"old_id":"76",
"old_nametree":"Paediatric cancer population",
"old_numtree":"3.10.1.0",
"old_htmlpage":"ENAS5193_3.10.1.0",
"new_id":"66",
"new_nametree":"Paediatric cancer population",
"new_numtree":"4.10.1.0",
"new_htmlpage":"ENAS5193_3.10.1.0"
},
{
"old_id":"77",
"old_nametree":"Elderly patients",
"old_numtree":"3.10.2.0",
"old_htmlpage":"ENAS5193_3.10.2.0",
"new_id":"67",
"new_nametree":"Elderly patients",
"new_numtree":"4.10.2.0",
"new_htmlpage":"ENAS5193_3.10.2.0"
},
{
"old_id":"78",
"old_nametree":"Pregnant women",
"old_numtree":"3.10.3.0",
"old_htmlpage":"ENAS5193_3.10.3.0",
"new_id":"68",
"new_nametree":"Pregnant women",
"new_numtree":"4.10.3.0",
"new_htmlpage":"ENAS5193_3.10.3.0"
},
{
"old_id":"79",
"old_nametree":"Prev. & attenuation of CV complications",
"old_numtree":"4.0.0.0",
"old_htmlpage":"null",
"new_id":"69",
"new_nametree":"Prev. & attenuation of CV complications",
"new_numtree":"5.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"80",
"old_nametree":"Tx in CTx-induced myocardial dysfunction",
"old_numtree":"4.1.0.0",
"old_htmlpage":"null",
"new_id":"70",
"new_nametree":"Tx in CTx-induced myocardial dysfunction",
"new_numtree":"5.1.0.0",
"new_htmlpage":"null"
},
{
"old_id":"81",
"old_nametree":"Before cardiotoxic cancer treatment",
"old_numtree":"4.1.1.0",
"old_htmlpage":"ENAS5193_4.1.1.0",
"new_id":"71",
"new_nametree":"Before cardiotoxic cancer treatment",
"new_numtree":"5.1.1.0",
"new_htmlpage":"ENAS5193_4.1.1.0"
},
{
"old_id":"82",
"old_nametree":"Patients with troponin elevation",
"old_numtree":"4.1.2.0",
"old_htmlpage":"ENAS5193_4.1.2.0",
"new_id":"72",
"new_nametree":"Patients with troponin elevation",
"new_numtree":"5.1.2.0",
"new_htmlpage":"ENAS5193_4.1.2.0"
},
{
"old_id":"83",
"old_nametree":"Patients w/ asymp. reduction in LVEF",
"old_numtree":"4.1.3.0",
"old_htmlpage":"ENAS5193_4.1.3.0",
"new_id":"73",
"new_nametree":"Patients w/ asymp. reduction in LVEF",
"new_numtree":"5.1.3.0",
"new_htmlpage":"ENAS5193_4.1.3.0"
},
{
"old_id":"84",
"old_nametree":"Patients w/ asymp. reduction in GLS",
"old_numtree":"4.1.4.0",
"old_htmlpage":"ENAS5193_4.1.4.0",
"new_id":"74",
"new_nametree":"Patients w/ asymp. reduction in GLS",
"new_numtree":"5.1.4.0",
"new_htmlpage":"ENAS5193_4.1.4.0"
},
{
"old_id":"85",
"old_nametree":"Patients with HF",
"old_numtree":"4.1.5.0",
"old_htmlpage":"ENAS5193_4.1.5.0",
"new_id":"75",
"new_nametree":"Patients with HF",
"new_numtree":"5.1.5.0",
"new_htmlpage":"ENAS5193_4.1.5.0"
},
{
"old_id":"86",
"old_nametree":"Non-pharmacological interventions",
"old_numtree":"4.1.6.0",
"old_htmlpage":"ENAS5193_4.1.6.0",
"new_id":"76",
"new_nametree":"Non-pharmacological interventions",
"new_numtree":"5.1.6.0",
"new_htmlpage":"ENAS5193_4.1.6.0"
},
{
"old_id":"87",
"old_nametree":"Prevention of TE events",
"old_numtree":"4.2.0.0",
"old_htmlpage":"ENAS5193_4.2.0.0",
"new_id":"77",
"new_nametree":"Prevention of TE events",
"new_numtree":"5.2.0.0",
"new_htmlpage":"ENAS5193_4.2.0.0"
},
{
"old_id":"88",
"old_nametree":"Attenuation of compli. w/ specific agents",
"old_numtree":"4.3.0.0",
"old_htmlpage":"null",
"new_id":"78",
"new_nametree":"Attenuation of compli. w/ specific agents",
"new_numtree":"5.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"89",
"old_nametree":"Anthracyclines",
"old_numtree":"4.3.1.0",
"old_htmlpage":"ENAS5193_4.3.1.0",
"new_id":"79",
"new_nametree":"Anthracyclines",
"new_numtree":"5.3.1.0",
"new_htmlpage":"ENAS5193_4.3.1.0"
},
{
"old_id":"90",
"old_nametree":"Her-2 targeted therapy",
"old_numtree":"4.3.2.0",
"old_htmlpage":"ENAS5193_4.3.2.0",
"new_id":"80",
"new_nametree":"Her-2 targeted therapy",
"new_numtree":"5.3.2.0",
"new_htmlpage":"ENAS5193_4.3.2.0"
},
{
"old_id":"91",
"old_nametree":"Pyrimidine analogues",
"old_numtree":"4.3.3.0",
"old_htmlpage":"ENAS5193_4.3.3.0",
"new_id":"81",
"new_nametree":"Pyrimidine analogues",
"new_numtree":"5.3.3.0",
"new_htmlpage":"ENAS5193_4.3.3.0"
},
{
"old_id":"92",
"old_nametree":"VEGF pathway inhibitors",
"old_numtree":"4.3.4.0",
"old_htmlpage":"ENAS5193_4.3.4.0",
"new_id":"82",
"new_nametree":"VEGF pathway inhibitors",
"new_numtree":"5.3.4.0",
"new_htmlpage":"ENAS5193_4.3.4.0"
},
{
"old_id":"93",
"old_nametree":"Radiotherapy",
"old_numtree":"4.3.5.0",
"old_htmlpage":"ENAS5193_4.3.5.0",
"new_id":"83",
"new_nametree":"Radiotherapy",
"new_numtree":"5.3.5.0",
"new_htmlpage":"ENAS5193_4.3.5.0"
},
{
"old_id":"94",
"old_nametree":"Surveillance for cancer survivors",
"old_numtree":"5.0.0.0",
"old_htmlpage":"null",
"new_id":"84",
"new_nametree":"Surveillance for cancer survivors",
"new_numtree":"6.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"95",
"old_nametree":"Overview",
"old_numtree":"5.1.0.0",
"old_htmlpage":"ENAS5193_5.1.0.0",
"new_id":"85",
"new_nametree":"Overview",
"new_numtree":"6.1.0.0",
"new_htmlpage":"ENAS5193_5.1.0.0"
},
{
"old_id":"96",
"old_nametree":"Myocardial dysfunction",
"old_numtree":"5.2.0.0",
"old_htmlpage":"ENAS5193_5.2.0.0",
"new_id":"86",
"new_nametree":"Myocardial dysfunction",
"new_numtree":"6.2.0.0",
"new_htmlpage":"ENAS5193_5.2.0.0"
},
{
"old_id":"97",
"old_nametree":"Vascular disease",
"old_numtree":"5.3.0.0",
"old_htmlpage":"ENAS5193_5.3.0.0",
"new_id":"87",
"new_nametree":"Vascular disease",
"new_numtree":"6.3.0.0",
"new_htmlpage":"ENAS5193_5.3.0.0"
},
{
"old_id":"98",
"old_nametree":"Valvular disease",
"old_numtree":"5.4.0.0",
"old_htmlpage":"ENAS5193_5.4.0.0",
"new_id":"88",
"new_nametree":"Valvular disease",
"new_numtree":"6.4.0.0",
"new_htmlpage":"ENAS5193_5.4.0.0"
},
{
"old_id":"99",
"old_nametree":"Future perspectives and research directions",
"old_numtree":"6.0.0.0",
"old_htmlpage":"ENAS5193_6.0.0.0",
"new_id":"89",
"new_nametree":"Future perspectives and research directions",
"new_numtree":"7.0.0.0",
"new_htmlpage":"ENAS5193_6.0.0.0"
},
{
"old_id":"100",
"old_nametree":"Abbreviations",
"old_numtree":"7.0.0.0",
"old_htmlpage":"ENAS5193_7.0.0.0",
"new_id":"90",
"new_nametree":"Abbreviations and acronyms",
"new_numtree":"8.0.0.0",
"new_htmlpage":"ENAS5193_7.0.0.0"
}
]